Avoid travelling with unlabelled or compounded vials, which can draw unnecessary scrutiny
Oral semaglutide for weight loss in non-diabetics is an approved option, meaning no diabetes diagnosis is necessary
semaglutide is a GLP-1 agonist only this explains tirzepatides superior weight loss Clinical evidence consistently favours Mounjaro: ~double the weight loss at 12 months in real-world data Side effects are similar for both primarily gastrointestinal, worst during dose escalation, improving over time Critical interactions: oral contraceptives, insulin, sulfonylureas, and warfarin Both are contraindicated in personal/family history of MTC or MEN 2, and during pregnancy Brand-name costs exceed $1,000/month without insurance
also discovered a link between renal cell ferroptosis and high glucose conditions, with diabetic mice and human renal proximal tubular (HK-2) cells under high glucose conditions displaying iron overload, reduced antioxidant capacity, ROS accumulation, and lipid peroxidation